Loading clinical trials...
Loading clinical trials...
Phase 1 of Exposure Targeted Melphalan Dosing
Conditions
Interventions
Autologous Hematopoietic Stem Cell Transplantation
Melphalan
+1 more
Locations
2
United States
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
University Illinois Chicago
Chicago, Illinois, United States
Start Date
May 20, 2021
Primary Completion Date
June 30, 2026
Completion Date
December 31, 2026
Last Updated
May 31, 2025
NCT06179888
NCT06152575
NCT04973605
NCT05201781
NCT06138275
NCT05862012
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions